Scientific Advisory Board
Amy Bastian, P.T., Ph.D.
Professor of neuroscience and neurology, Johns Hopkins University School of Medicine.
Chief Science Officer, Kennedy Krieger Institute
Director, Motion Analysis Laboratory Kennedy Krieger Institute
Michael Johnston, M.D.
Professor of neurology and pediatrics, Johns Hopkins University School of Medicine
Executive Vice President and Chief Medical Officer, Kennedy Krieger Institute
Adam Kirton, M.D., MSc
Professor of Pediatrics and Clinical Neurosciences, University of Calgary
Attending Pediatric Neurologist, Alberta Children’s Hospital
Director, Calgary Pediatric Stroke Program,
Director, Alberta Perinatal Stroke Project,
Director, ACH Pediatric Non-Invasive Brain Stimulation Laboratory,
Alberta Children's Hospital
Barry Kosofsky, M.D., Ph.D.
Weill Cornell Medicine
Horace W. Goldsmith Foundation Professor of Pediatrics in Radiology, Neurology, and Neuroscience at Weill Cornell Medicine
Chief, Division of Pediatric Neurology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Attending Pediatrician at NewYork-Presbyterian Hospital and NYP Komansky Children's Hospital.
Director of the Horace W. Goldsmith Foundation Laboratory of Molecular and Developmental Neuroscience
William Mobley, M.D., Ph.D.
UC, San Diego
Florence Riford Chair of Alzheimer Disease Research.
Executive Director of UCSD's Down Syndrome Center for Research and Treatment.
Nicholas Schiff, M.D.
Weill Cornell Medicine
Jerold B. Katz Professor of Neurology and Neuroscience Feil Family Brain and Mind Research Institute
Professor of Public Health
Co-Director, Consortium for the Advanced Study of Brain Injury (CASBI)
Darryl De Vivo, M.D.
Sidney Carter Professor of Neurology, Professor of Pediatrics, and Director Emeritus (1979-2000) of the Pediatric Neurology Service at Columbia University Medical Center
Jonathan Wolpaw, M.D.
Director of the National Center for Adaptive Neurotechnologies
David Axelrod Institute, Wadsworth Center
NYS Department of Health
Joint Steering Committee
Rajiv Ratan, M.D., Ph.D.
Executive Director, Burke Neurological Institute
President & CEO, Blythedale Children’s Hospital
Scott Klein, M.D., M.H.S.A.
Chief Medical Officer & Chief of Pediatrics, Blythedale Children’s Hospital
Chief Financial Officer, Blythedale Children’s Hospital
Chair, Board of Trustees, Blythedale Children’s Hospital
Former Chair, Board of Trustees, Blythedale Children’s Hospital
Robert J. Baldoni
Chair, Board of Trustees, Burke Neurological Institute
Vice Chair, Board of Trustees, Burke Neurological Institute
Institutional Review Board
The Institutional Review Board (IRB) at Blythedale Children’s Hospital strives
- To promote ethical research;
- To protect research participant’s rights;
- To ensure compliance with Federal regulations; and
- To protect the interests of the institution.
Research conducted at Blythedale using human participants, is overseen by Blythedale's IRB. Its purpose is to facilitate human subjects research and to ensure the rights and welfare of human subjects are protected during their participation. The board weighs the risks and benefits of participation to help protect the health and best interests of research participants.
IRB Board Members
September 20, 2018
November 8, 2018